LAUREN BROWN: Open Payments
NPI 1659033363 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,515 in 42 payments from 18 companies in 2025. Trend: 2023 $1,395 · 2024 $2,016 · 2025 $1,515
Food & beverage: $1,515
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $244 |
| Alnylam Pharmaceuticals Inc. | 5 | $215 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $205 |
| Edwards Lifesciences Corporation | 1 | $160 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $137 |
| ABIOMED | 1 | $116 |
| Novo Nordisk Inc | 5 | $91 |
| Novartis Pharmaceuticals Corporation | 4 | $70 |
| Daiichi Sankyo Inc. | 3 | $55 |
| Chiesi USA, Inc. | 2 | $52 |
Products named: LifeVest, AMVUTTRA, SAPIEN 3 Ultra RESILIA, JARDIANCE, CAMZYOS, Wegovy, LEQVIO, INJECTAFER.
Industry payments across OK — which companies pay providers there.
